Suministro de Asociación de Formoterol, Glicopirronio y Budesonida (DOE) — TenderRadar

Suministro de Asociación de Formoterol, Glicopirronio y Budesonida (DOE)

TED · 540819-2026Award noticeawardedNo deadline given

Buyer

NameOSAKIDETZA - Servicio Vasco de Salud - Organización Central

CountryES

Published2026-08-05

Deadline—

Value

Estimated€258,060 · 258,060 EUR

Awarded€215,050 · 215,050 EUR

WinnerASTRAZENECA FARMACEUTICA SPAIN, S.A.

See this firm's wins →

Who already wins at this buyer

Firms with recorded awards from OSAKIDETZA - Servicio Vasco de Salud - Organización Central in this tender’s CPV categories — the incumbents you are bidding against.

Firm	Wins	Awarded	Last win
MEDTRONIC IBERICA, S.A. \| BOSTON SCIENTIFIC IBERICA, S.A. \| ABBOTT MEDICAL ESPAÑA, S.A. \| BIOSENSORS IBERIA, S.L. \| B. BRAUN SURGICAL, S.A. \| WORLD MEDICA, S.L. \| PALEX MEDICAL, S.A. \| IZASA HOSPITAL, S.L.U. \| CARDIVA 2, S.L. \| TERUMO EUROPE ESPAÑA, S.L. \| IBERHOSPITEX, S.A. \| BIOTRONIK SPAIN, S.A. \| LOGISTICA Y SUMINISTROS SANITARIOS, S.L. \| SAHAJANAND MEDICAL TECHNOLOGIE IBERIA SL \| BIOMENCO, S.L. \| CARDIOLINK SL \| HEXACATH ESPAÑA, S.L. \| LECUMBERRI SUMINISTROS, S.L.U. \| CARDINAL HEALTH SPAIN 511 , S.L. \| ORBUSNEICH MEDICAL, S.L. \| PRIM, S.A. \| BALT SPAIN MEDICAL, S.L. \| BIOGEN DIAGNOSTICA S.L. \| CIRCINORMED, S.L.	3	€57,232,556	2026-08-04
EDWARDS LIFESCIENCIES, S.L. \| ABBOTT MEDICAL ESPAÑA SA \| MEDTRONIC IBÉRICA, S.A. \| BOSTON SCIENTIFIC IBÉRICA, S.A. \| MERCÉ V. ELECTROMEDICINA, S.L. \| PALEX MEDICAL \| SAGITTAE MEDICAL S.L \| SERMEBI 97 SL	3	€24,084,632	2026-07-13
ASTRAZENECA FARMACEUTICA SPAIN, S.A.	3	€11,241,391	2026-06-03
TAKEDA FARMACÉUTICA ESPAÑA, S.A.	3	€8,594,135	2026-07-21
PFIZER S L	3	€3,078,902	2026-06-19

Full buyer profile: what OSAKIDETZA - Servicio Vasco de Salud - Organización Central buys and who wins it →

CPV codes

33600000 Medical equipment & pharmaceuticals

Description

Suministro de Asociación de Formoterol, Glicopirronio y Budesonida (DOE)

Source

View the official notice on TED ↗